Watch: Big Week For Drug Pricing Debate Featured On C-SPAN
KHN correspondent Emmarie Huetteman appeared on the C-SPAN program “Washington Journal,” where she fielded viewers’ calls about high drug prices and industry criticism.
U.S. Congress
621 - 640 of 993 Results
-
-
Podcast: KHN’s ‘What The Health?’ ‘Medicare-For-All’ Debate: Who’s Going To Pay
Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Jennifer Haberkorn of the Los Angeles Times join KHN’s Julie Rovner to discuss the new “Medicare-for-all” bill introduced by House Democrats, the grilling of pharmaceutical company CEOs by a Senate committee and new Trump administration rules that take aim at Planned Parenthood. Plus, Rovner interviews KHN’s Julie Appleby about the latest “Bill of the Month” installment.
-
There’s A New ‘Medicare-For-All’ Bill In The House. Why Does It Matter?
The progressive proposal adds details to the discussion of this controversial approach to overhauling the nation’s health system, and Democratic primary candidates will have to be prepared to get more specific.
-
Detention Centers In California Lack Oversight And Proper Care, Reports Find
Health and safety problems at immigration detention facilities throughout California pose a serious risk to detainees, according to two reports released Tuesday. State Attorney General Xavier Becerra and California State Auditor Elaine Howle concluded that federal and local governments are failing to adequately oversee the facilities, allowing the problems to persist.
By Anna Gorman and Ana B. Ibarra -
Pharma Execs Dig In For A Fight Against Outraged Senators
The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.
By Emmarie Huetteman and Jay Hancock -
Congress Squares Off With Pharma CEOs In Showdown Over High Drug Prices
Tuesday’s Senate Finance Committee hearing could produce fireworks over prices, R&D costs and executive compensation.
By Emmarie Huetteman and Jay Hancock -
Video: High Drama No Stranger At Congressional Health Care Hearings
Most hearings before the U.S. House and Senate are routine affairs. But a few tense moments featuring everyone from Hillary Clinton to tobacco CEOs drew the attention of millions of Americans.
By Julie Rovner and Mary Agnes Carey -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
Tuesday’s Senate hearing with pharma CEOs will tackle the same issues as the famous Kefauver hearings in 1960.
By Jay Hancock -
Today’s Concerns About Drug Prices Echo The Past
Confrontational hearings 60 years ago sparked remarkably similar quotes about drug prices and health care policy.
-
Podcast: KHN’s ‘What The Health?’ How Safe Are Your Supplements?
Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the latest national health spending estimates, another FDA crackdown on dietary supplements and lawsuits between insurers and the federal government that could result in a windfall for consumers.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
Podcast: KHN’s ‘What The Health?’ ‘Medicare-For-All’ For Dummies
The “Medicare–for-all” debate is already in full swing, but what does that phrase even mean? Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner for a beginner’s guide to the next big health policy debate. For “extra credit,” the panelists provide their favorite health policy stories of the week, and as a special Valentine’s Day bonus, their favorite #HealthPolicyValentines.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
Trump’s Pediatric Cancer Crusade A Drop In Bucket Compared With Past Presidential Pitches
President Donald Trump wants Congress to allot $500 million over 10 years for pediatric cancer research. While it’s welcomed by researchers and advocates, it’s not a lot of money.
-
John Dingell, ‘Dean Of The House,’ Remembered As A Force In Health Policy
The Michigan Democrat chaired the House Energy and Commerce Committee and his impact on health care was immense.
By Julie Rovner -
Trump Pledges To End HIV Transmission By 2030. Doable, But Daunting.
The president’s promise to eliminate HIV transmission within 10 years is a goal long sought by advocates, but it won’t be an easy undertaking.
-
Trump Highlights Health Agenda With Vow To Lower ‘Unfair’ Drug Prices
The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.
By Julie Rovner -
Ideas To Curb Surprise Medical Bills Percolate With Rare Bipartisan Push
The recent declaration by President Donald Trump that taming unexpected medical bills would be a top priority for his administration echoed through the halls of Congress.
By Shefali Luthra and Emmarie Huetteman -
For California Attorney General Xavier Becerra, Resistance Is Personal
Xavier Becerra, the state’s first Latino attorney general, is one of President Donald Trump’s most relentless adversaries. He attributes his legal values — and his opposition to the current administration — to his upbringing as the son of Mexican immigrants.